ChineseInvestors.com, Inc. (OTCQB: CIIX), developer of a proprietary financial news media and content platform providing information to the global Chinese-speaking community, this morning announced that its subsidiary, CBD Biotechnology Co. Ltd., has entered into Alibaba Group’s (NYSE: BABA) Tmall, China’s largest e-commerce marketplace for brands and retailers. Per the agreement, Tmall will feature CBD Biotechnology’s skincare line for its 500 million registered customers, substantially expanding the company’s reach ahead of the upcoming Double 11, also known as Singles’ Day, and Double 12 Shopping Festivals. “CBD Biotechnology Co. Ltd. is not only one of the first companies to produce and sell CBD skincare products in China, but now it is the first CBD skincare company to enter Tmall. We now have significantly extended our sales channel and through our dedication in educating our audience on the benefits of our product, believe that we are on the path to strengthening our brand influence for the massive cosmetics industry within China and the global Chinese community. From October 15 through the end of December 2018, our company will invest 2.5 million RMB in online marketing and advertising for all of our CBD skincare product lines. The total single day volume of transactions during the Double Eleven Shopping Festival in 2017 reached 168.2 billion. We are thrilled to be participating in the Double 11 and Double 12 Shopping Festivals this year.” Chineseinvestors.com CEO Warren Wang stated in the news release.
To view the full press release, visit https://cnw.fm/ClV2j
Founded in 1999, Chineseinvestors.com has developed a proprietary financial news media and content platform providing information to the global Chinese-speaking community, in China, the United States, Canada and around the world. This platform provides access to the estimated 20 percent of the global population that speaks Mandarin, the largest language group in the world. The Company is leveraging this platform and expanding its offerings to include additional products and services. The Company has launched, through its wholly owned subsidiaries CBD Biotechnology Co. LTD. and ChineseHempOil.com, Inc., the websites ChineseHempOil.com and uscbd.net, to generate online sales of the Company’s industrial hemp-derived CBD products in both the US and China. These assets make ChineseInvestors.com, Inc. the world’s first U.S. publicly traded company promoting hemp-derived CBD products for the Chinese community. Chineseinvestors.com has headquarters in San Gabriel, California with primary offices and facilities in New York and Shanghai, China. For more information, visit the company’s website at www.ChineseInvestors.com